Mei Pharma, Inc. (MEIP)

Trade MEIP now with
6/22/2022 8:08:29 AM MEI Pharma Appoints Human Resources Executive Anne Frese As Chief People Officer
6/10/2022 3:31:49 AM MEI Pharma And Kyowa Kirin Report Clinical Data On Zandelisib At European Hematology Association 2022 Hybrid Congress
5/23/2022 4:28:19 PM MEI Pharma Q3 Loss/share $0.07 Vs. Loss $0.23 Year Ago
12/6/2021 4:05:08 PM MEI Pharma Announces Closing Of Public Offering Of Common Stock
12/1/2021 8:51:44 PM MEI Pharma Prices Public Offering Of 17.50 Mln Shares At $2.60/shr
11/10/2021 8:12:43 AM MEI Pharma And Kyowa Kirin Receive Orphan Drug Designation For Zandelisib For Treatment Of Follicular Lymphoma
8/17/2021 8:08:25 AM MEI Pharma Says First Patient Dosed In Phase 3 COASTAL Study On Refractory Indolent Non Hodgkin's B-cell Lymphoma
7/7/2021 8:02:42 AM MEI Pharma Appoints Tina Beamon As Chief Compliance Officer
6/9/2021 6:02:38 AM MEI Pharma And Kyowa Kirin To Present Clinical Data From Studies Evaluating Zandelisib For Lymphoma At ICML
6/7/2021 8:14:26 AM MEI Pharma, Kyowa Kirin Announce First Patient With Marginal Zone Lymphoma Dosed In Expanded Global Phase 2 TIDAL Study
4/30/2021 9:01:42 AM MEI Pharma Announces Retirement Of Robert Mass Chief Medical Officer
4/13/2021 7:10:01 AM MEI Pharma,Kyowa Kirin Complete Enrollment In Follicular Lymphoma Primary Efficacy Population Of Phase 2 TIDAL Study
1/4/2021 7:38:41 AM MEI Pharma Reports Expansion Of Phase 1b Study Evaluating Zandelisib
8/2/2016 11:05:06 AM Wedbush Is Lowering MEI Pharma, Inc. (MEIP) 2016 Estimate To -0.58 From -0.57
8/2/2016 11:04:32 AM Wedbush Reiterates MEI Pharma, Inc. (MEIP) At Neutral With $2 Price Target
3/23/2015 3:22:28 PM Stifel Cuts MEI Pharma, Inc. (MEIP) To Hold From Buy